Ramsay Generale de Sante SA (FR:GDS)
:GDS
GDS Stock Chart & Stats
€9.34
€0.00(0.00%)
At close: 4:00 PM EST
€9.34
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€8.72 - €11.25
Previous CloseN/A
Volume15.00
Average Volume (3M)31.35K
Market Cap
€1.13B
Enterprise Value€6.78B
Total Cash (Recent Filing)€218.10M
Total Debt (Recent Filing)€5.86B
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.32
Shares Outstanding110,389,690
10 Day Avg. Volume445
30 Day Avg. Volume31,348
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.06
Price to Sales (P/S)0.23
P/FCF Ratio2.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GrowthA 25.21% free cash flow growth rate indicates durable cash generation from operations. Persistent FCF growth provides capacity to fund maintenance capex, service debt, and invest in facility upgrades without relying solely on equity, supporting operational resilience over months.
Stable Revenue GenerationConsistent revenue growth, even if modest, reflects stable patient volumes and reimbursement under the French healthcare system. Predictable top-line trends reduce execution risk and support planning for capacity utilization, staffing, and gradual service expansion over the medium term.
Strong Gross Profit MarginsA robust gross margin shows core hospital operations generate healthy contribution per case. That operational efficiency gives management levers to restore net profitability via overhead control or reduced financial costs, and supports long-term margins if case mix and utilization remain stable.
Bears Say
High LeverageSignificant leverage increases financial risk, constraining flexibility to invest or absorb shocks. Elevated debt levels raise interest expense and refinancing needs, making the company sensitive to funding market conditions and potentially limiting strategic initiatives over the next several quarters.
Negative Net Margin And ROENegative net income and ROE indicate the company is not currently generating returns for shareholders. Persistent losses erode equity, limit retained earnings, and reduce ability to fund growth internally or return capital, creating a structural hurdle to long-term investor value creation.
Cash Flow Not Fully Translating To ProfitsA disconnect where strong FCF does not convert to positive net income may reflect high financial costs, depreciation, or one-off items. This gap complicates recovery because operational cash strength may be absorbed by non-operating expenses, limiting durable improvement in reported earnings.
Ramsay Generale de Sante News
GDS FAQ
What was Ramsay Generale de Sante SA’s price range in the past 12 months?
Ramsay Generale de Sante SA lowest stock price was €8.72 and its highest was €11.25 in the past 12 months.
What is Ramsay Generale de Sante SA’s market cap?
Ramsay Generale de Sante SA’s market cap is €1.13B.
When is Ramsay Generale de Sante SA’s upcoming earnings report date?
Ramsay Generale de Sante SA’s upcoming earnings report date is Aug 20, 2026 which is in 137 days.
How were Ramsay Generale de Sante SA’s earnings last quarter?
Ramsay Generale de Sante SA released its earnings results on Feb 25, 2026. The company reported -€0.316 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.316.
Is Ramsay Generale de Sante SA overvalued?
According to Wall Street analysts Ramsay Generale de Sante SA’s price is currently Overvalued.
Does Ramsay Generale de Sante SA pay dividends?
Ramsay Generale de Sante SA pays a Semiannually dividend of €0.791 which represents an annual dividend yield of N/A. See more information on Ramsay Generale de Sante SA dividends here
What is Ramsay Generale de Sante SA’s EPS estimate?
Ramsay Generale de Sante SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ramsay Generale de Sante SA have?
Ramsay Generale de Sante SA has 110,389,690 shares outstanding.
What happened to Ramsay Generale de Sante SA’s price movement after its last earnings report?
Ramsay Generale de Sante SA reported an EPS of -€0.316 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.926%.
Which hedge fund is a major shareholder of Ramsay Generale de Sante SA?
Currently, no hedge funds are holding shares in FR:GDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ramsay Generale de Sante SA
Ramsay Générale de Santé SA operates hospitals in France. Its hospitals offer a range of services in the areas of anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology, as well as thoracic, vascular, and endovascular surgeries. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. Ramsay Générale de Santé SA was founded in 1987 and is based in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.